Citigroup’s Catheter Precision VTAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1 Buy
+1
New +$2 ﹤0.01% 5875
2022
Q3
Hold
0
6355
2022
Q2
Sell
-5
Closed -$15.5K 6701
2022
Q1
$21K Buy
+5
New +$34K ﹤0.01% 5124
2021
Q1
Hold
0
7474
2020
Q4
Hold
0
7654
2018
Q4
Hold
0
-$8K 7848
2018
Q3
Hold
0
7416

Other funds holding VTAK

Citigroup's VTAK Position: Q1 2026 in Review

Citigroup opened a new position in Catheter Precision (VTAK) in Q1 2026: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #5875 among its holdings. This is a return to the name: Citigroup previously reported a position in VTAK as recently as Q1 2022.

Citigroup first reported a position in VTAK in Q1 2022 and has held it in 2 quarters since. The position peaked at $21K in Q1 2022. 12 funds tracked by Wall St. Rank hold VTAK as of Q1 2026.

  • Citigroup held 1 share of Catheter Precision worth $1 as of Q1 2026.
  • Catheter Precision was a new Citigroup position in Q1 2026.
  • Catheter Precision made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5875 holding.
  • Citigroup first reported a position in Catheter Precision in Q1 2022 and has held it in 2 quarters since.
  • Citigroup's Catheter Precision position peaked at $21K in Q1 2022.
  • 12 funds tracked by Wall St. Rank held Catheter Precision as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.